Desvenlafaxine: all 51 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• The Efficacy and Safety of Pregabalin Combined With Desvenlafaxine in Patients With FibromyalgiaRecruitingNCT07171320Not applicable
• A Study of MD-120 in Patients With DepressionCompletedNCT04345471Phase 3Results posted
• Desvenlafaxine vs. Placebo Treatment of Chronic DepressionCompletedNCT01537068Phase 4Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)CompletedNCT01432457Phase 4Results posted
• A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedNCT01372150Phase 3Results posted
• 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety DisorderCompletedNCT01316302Phase 4Results posted
• Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)CompletedNCT01190514Phase 1Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)CompletedNCT01121484Phase 4Results posted
• Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral NeuropathyTerminatedNCT01050218Phase 3Results posted
• Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive DisorderCompletedNCT00887224Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive DisorderCompletedNCT00798707Phase 3Results posted
• Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy SubjectsCompletedNCT00727064Phase 1Results posted
• Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal WomenCompletedNCT00683800Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenCompletedNCT00406640Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive DisorderCompletedNCT00384033Phase 3Results posted
• Desvenlafaxine for Preventive Treatment of Frequent MigrainesActive, not recruitingNCT07385755Not applicable
• Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type HeadacheActive, not recruitingNCT07359248Not applicable
• Predictors of Cognitive Outcomes in Geriatric DepressionActive, not recruitingNCT05273996Phase 4
• A Study of LY03005 vs PristiqCompletedNCT03733574Phase 1
• Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®CompletedNCT03357796Phase 1
• Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine TreatmentCompletedNCT02859103Phase 4
• Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking TamoxifenTerminatedNCT02819921Phase 4
• Prediction of Antidepressant Treatment Response Using Machine Learning Classification AnalysisStatus unknownNCT02330679Phase 4
• Desvenlafaxine in Opioid-Dependent PatientsCompletedNCT02200406Phase 4
• Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other ComorbitiesCompletedNCT01975480Phase 4
• Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular DepressionStatus unknownNCT01974934Phase 4
• Desvenlafaxine Monotherapy in DysthymiaCompletedNCT01948895Not applicable
• Functional Outcome in Postpartum Depression in Women Treated With DesvenlafaxineCompletedNCT01527786Phase 3
• Effect of Antidepressants on White Matter StructureStatus unknownNCT01492621Phase 4
• Neurocognition and Work Productivity in Major Depressive Disorder (MDD)CompletedNCT01468610Not applicable
• Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release TabletCompletedNCT01443208Phase 1
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive DisorderCompletedNCT01309542Phase 3
• Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy VolunteersStatus unknownNCT01101152Phase 1
• Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and WomenStatus unknownNCT00888862Phase 3
• Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and FemalesCompletedNCT00818155Phase 1
• Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive DisorderCompletedNCT00452595Phase 3
• Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With MenopauseCompletedNCT00421031Phase 3
• Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal WomenCompletedNCT00369434Phase 3
• Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy SubjectsCompletedNCT00329186Phase 3
• Study Evaluating the Efficacy of DVS-233 in FibromyalgiaTerminatedNCT00301431Phase 2/3
• Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive DisorderCompletedNCT00300378Phase 3
• Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With MenopauseCompletedNCT00256685Phase 3
• Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive DisorderCompletedNCT00242229Not applicable
• Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With MenopauseCompletedNCT00195546Phase 3
• Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive DisorderCompletedNCT00092911Phase 3
• Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive DisorderCompletedNCT00090649Phase 3
• Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive DisorderCompletedNCT00087737Phase 3
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00075257Phase 3
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00073762Phase 3
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderCompletedNCT00072774Phase 3
• Study Evaluating DVS-233 in Adult Outpatients With Major Depressive DisorderCompletedNCT00063206Phase 3

← Desvenlafaxine overview